From Financial Modeling Prep: 2024-10-22 20:00:03

Quest Diagnostics Incorporated, listed as NYSE:DGX, reported earnings per share (EPS) of $5.72, surpassing market expectations. The company’s revenue reached $2.49 billion, exceeding the estimated $2.42 billion. Quest Diagnostics adjusted its 2024 profit forecast to $8.85-$8.95 per share, with a revenue forecast of $9.80-$9.85 billion, driven by recent acquisitions and strong performance.



Read more at Financial Modeling Prep:: Quest Diagnostics Incorporated’s Impressive Financ…